Regrowing hearing cells: New gene functions discovered in zebrafish offer clues for future hearing loss treatments
Peer-Reviewed Publication
Updates every hour. Last Updated: 4-Oct-2025 22:11 ET (5-Oct-2025 02:11 GMT/UTC)
H5N1 influenza outbreaks have been reported on more than 1.070 dairy farms in the United States since 2024. The virus severely affects the mammary glands and contaminates the milk, posing a threat to the global dairy industry and public health. The way the virus invades the mammary glands of dairy cattle remains a mystery. A recent study by Shi. et al found that the cows' unique "milk-stealing" behavior is the cause of the virus invading their mammary glands and triggering the outbreaks, and that vaccination would be a practical strategy for controlling this disease.
Scientists from the Marine Biological Association and the University of Plymouth have revisited turn-of-the-century forecasts about the many and varied threats they thought were likely to face the world’s shorelines in 2025. Their new study highlights that many of their forecasts were correct, either in whole or in part, while others haven’t had the impacts that were envisaged at the time. They have also charted some of the other threats to have emerged and/or grown in significance since their original work, with notable examples including global plastic pollution, ocean acidification, extreme storms and weather, and light and noise pollution.
The public, legislators, and media often group per- and polyfluoroalkyl substances, known as PFAS or “forever chemicals,” which are found globally in countless products, into a single category. While certain PFAS are harmful for human and public health, new articles in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier, emphasize that fluoropolymers, a specific class of PFAS, are not considered environmental contaminants and are indispensable for use in medical devices. Experts call for a balanced approach to protect both the environment and availability of essential medical technologies.
Singapore researchers have discovered that a Singapore-developed cancer drug, originally developed at A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB), shows potential as a new treatment approach for two leading causes of blindness worldwide. In pre-clinical studies published in Nature Communications, PRL3-zumab effectively reduced leakage from damaged blood vessels—a major cause of vision loss—showing promise as a potential new treatment for patients whose conditions do not respond well to current therapies.